Development of an international core outcome set for treatment trials in paediatric inguinal hernia: protocol for a

Sanne C Maat1,2,3, Ramon R Gorter2, Ernest L W van Heurn4,3

  • 1Department of Pediatric Surgery, Amsterdam Reproduction and Development Research Institute, Emma Childrens' Hospital UMC, Amsterdam, The Netherlands s.c.maat@amsterdamumc.nl.

BMJ Open
|December 14, 2023
PubMed

Insights

This study aims to establish a core outcome set for pediatric inguinal hernia repair to standardize reporting and improve treatment comparisons. Developing this consensus will address heterogeneity in current research, leading to clearer evidence on surgical approaches.

Area of Science:

  • Pediatric surgery
  • Clinical trial methodology

Background:

  • Open inguinal hernia repair is standard in children, but laparoscopic techniques are emerging.
  • Lack of consensus on surgical superiority stems from inconsistent outcome reporting in trials.
  • A core outcome set (COS) is needed to standardize outcome measurement and reporting in pediatric inguinal hernia repair.

Purpose of the Study:

  • To achieve international consensus on a minimal set of outcomes for pediatric inguinal hernia repair trials.
  • To reduce heterogeneity in outcome selection, measurement, and reporting across studies.
  • To facilitate evidence-based decision-making for surgical treatment strategies.

Main Methods:

  • Systematic literature review to identify outcome domains from patient and literature perspectives.
  • Three-round Delphi study involving stakeholders to prioritize core outcomes.
  • Expert consensus meeting to finalize the COS and develop implementation strategies.

Main Results:

  • The project is in its development phase, aiming to establish a COS.
  • The methodology involves systematic reviews, Delphi studies, and expert consensus.
  • The final COS will be reported following COS-Standards for Reporting.

Conclusions:

  • A standardized core outcome set is crucial for advancing research in pediatric inguinal hernia repair.
  • This initiative will improve the quality and comparability of clinical trials.
  • The developed COS will guide future research and clinical practice, ultimately benefiting patient outcomes.
Abstract